Medical Research
(H12)
IRS Verified
DX Registered
ADENOID CYSTIC CARCINOMA RESEARCHFOUNDATION
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$1.9M
Total Revenue
$1.9M
Total Expenses
$2.5M
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
92.1%
Fundraising Efficiency
0.0%
Operating Reserve
16.30x
Liability-to-Asset
5.5%
Revenue Diversification
55.7%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.9M | $1.9M | $2.5M | 92.1% | 3 |
| 2022 | $1.4M | $1.6M | N/A | — | 2 |
| 2021 | $2.4M | $2.1M | N/A | — | 2 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.